Variant report
Variant | rs9693589 |
---|---|
Chromosome Location | chr8:11348961-11348962 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:26)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:26 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | FOXM1 | chr8:11348939-11352758 | GM12878 | blood: | n/a | n/a |
2 | BCLAF1 | chr8:11348871-11353485 | GM12878 | blood: | n/a | chr8:11350566-11350575 chr8:11349705-11349714 chr8:11349172-11349179 |
3 | NFIC | chr8:11348816-11353401 | GM12878 | blood: | n/a | chr8:11352085-11352101 |
4 | POLR2A | chr8:11348731-11357871 | GM12878 | blood: | n/a | n/a |
5 | POLR2A | chr8:11348849-11349227 | GM12891 | blood: | n/a | n/a |
6 | POLR2A | chr8:11348901-11349162 | GM12878 | blood: | n/a | n/a |
7 | RELA | chr8:11348954-11351628 | GM10847 | blood: | n/a | n/a |
8 | POLR2A | chr8:11348894-11357440 | GM12878 | blood: | n/a | n/a |
9 | POLR2A | chr8:11348840-11353431 | Raji | blood: | n/a | n/a |
10 | POLR2A | chr8:11348797-11357460 | GM12878 | blood: | n/a | n/a |
11 | POLR2A | chr8:11348826-11357664 | GM18505 | blood: | n/a | n/a |
12 | YY1 | chr8:11348929-11349201 | GM12878 | blood: | n/a | chr8:11349097-11349108 |
13 | PML | chr8:11348838-11353257 | GM12878 | blood: | n/a | n/a |
14 | POLR2A | chr8:11348927-11353187 | GM12878 | blood: | n/a | n/a |
15 | MTA3 | chr8:11348542-11357777 | GM12878 | blood: | n/a | n/a |
16 | NFYB | chr8:11348806-11349021 | GM12878 | blood: | n/a | n/a |
17 | ATF2 | chr8:11348914-11352994 | GM12878 | blood: | n/a | n/a |
18 | YY1 | chr8:11348912-11349969 | GM12878 | blood: | n/a | chr8:11349097-11349108 |
19 | RUNX3 | chr8:11348819-11353505 | GM12878 | blood: | n/a | n/a |
20 | RUNX3 | chr8:11348786-11351377 | GM12878 | blood: | n/a | n/a |
21 | POLR2A | chr8:11348933-11349170 | GM12878 | blood: | n/a | n/a |
22 | POLR2A | chr8:11348798-11353058 | GM12892 | blood: | n/a | n/a |
23 | NFIC | chr8:11348885-11352575 | GM12878 | blood: | n/a | chr8:11352085-11352101 |
24 | POU2F2 | chr8:11348869-11352671 | GM12878 | blood: | n/a | chr8:11349446-11349454 chr8:11349440-11349461 chr8:11349445-11349455 chr8:11349445-11349456 chr8:11351837-11351849 chr8:11349441-11349459 |
25 | POLR2A | chr8:11348956-11352660 | GM12892 | blood: | n/a | n/a |
26 | POLR2A | chr8:11348812-11353227 | GM12892 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
BLK | TF binding region |
rs_ID | r2[population] |
---|---|
rs13277113 | 0.98[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1382568 | 0.93[ASN][1000 genomes] |
rs1478887 | 0.91[ASN][1000 genomes] |
rs1478895 | 0.83[ASN][1000 genomes] |
rs1478900 | 0.85[ASN][1000 genomes] |
rs1478901 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs2061831 | 0.83[AFR][1000 genomes];0.89[AMR][1000 genomes];0.94[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs2250412 | 0.82[ASN][1000 genomes] |
rs2250788 | 0.83[ASN][1000 genomes] |
rs2251056 | 0.83[ASN][1000 genomes] |
rs2254546 | 0.82[ASN][1000 genomes] |
rs2254891 | 0.80[ASN][1000 genomes] |
rs2409780 | 0.85[AFR][1000 genomes];0.88[AMR][1000 genomes];0.94[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs2618444 | 0.83[AFR][1000 genomes];0.88[AMR][1000 genomes];0.94[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs2618473 | 0.95[AMR][1000 genomes];0.93[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs2618476 | 1.00[AFR][1000 genomes];0.95[AMR][1000 genomes];0.96[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs2618478 | 0.82[ASN][1000 genomes] |
rs2618479 | 0.82[ASN][1000 genomes] |
rs2618480 | 0.83[ASN][1000 genomes] |
rs2618481 | 0.93[ASN][1000 genomes] |
rs2736332 | 0.89[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs2736336 | 0.86[AMR][1000 genomes];0.94[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs2736337 | 0.87[AMR][1000 genomes];0.92[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs2736338 | 0.87[AMR][1000 genomes];0.92[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs2736340 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs2736343 | 0.83[ASN][1000 genomes] |
rs2736344 | 0.83[ASN][1000 genomes] |
rs2736345 | 0.84[ASN][1000 genomes] |
rs4840565 | 0.83[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs4840568 | 0.94[AMR][1000 genomes];0.93[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs922483 | 0.81[AMR][1000 genomes];0.83[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs9694294 | 0.83[ASN][1000 genomes] |
rs998682 | 0.83[ASN][1000 genomes] |
rs998683 | 0.98[AFR][1000 genomes];0.95[AMR][1000 genomes];0.96[EUR][1000 genomes];0.99[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv1035072 | chr8:10819444-11480692 | Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Strong transcription Flanking Active TSS Bivalent/Poised TSS Active TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 50 gene(s) | inside rSNPs | diseases |
2 | nsv539473 | chr8:10819444-11480692 | Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Strong transcription Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 50 gene(s) | inside rSNPs | diseases |
3 | nsv529399 | chr8:10970091-11805960 | Enhancers Strong transcription Weak transcription Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 54 gene(s) | inside rSNPs | diseases |
4 | esv34097 | chr8:11177372-11489894 | Weak transcription Flanking Active TSS Enhancers Strong transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 17 gene(s) | inside rSNPs | diseases |
5 | nsv1022074 | chr8:11292256-11394526 | Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 4 gene(s) | inside rSNPs | diseases |
6 | esv2762725 | chr8:11322997-11350721 | Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer Genic enhancers Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 4 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:11338200-11350000 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
2 | chr8:11339000-11353800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr8:11344200-11353800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr8:11348000-11349200 | Enhancers | Primary B cells from peripheral blood | blood |
5 | chr8:11348000-11350200 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
6 | chr8:11348400-11349800 | Enhancers | Primary B cells from cord blood | blood |
7 | chr8:11348600-11349400 | Flanking Active TSS | GM12878-XiMat | blood |